James Investment Research Inc. Decreases Position in The Cigna Group (NYSE:CI)

James Investment Research Inc. decreased its holdings in The Cigna Group (NYSE:CI - Free Report) by 31.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,122 shares of the health services provider's stock after selling 2,838 shares during the period. James Investment Research Inc.'s holdings in The Cigna Group were worth $1,691,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Collier Financial purchased a new position in shares of The Cigna Group in the fourth quarter valued at about $32,000. ORG Wealth Partners LLC purchased a new position in shares of The Cigna Group in the fourth quarter valued at about $34,000. Prospera Private Wealth LLC purchased a new position in shares of The Cigna Group in the third quarter valued at about $37,000. Compagnie Lombard Odier SCmA purchased a new position in shares of The Cigna Group in the fourth quarter valued at about $37,000. Finally, Harbor Capital Advisors Inc. purchased a new stake in shares of The Cigna Group in the third quarter worth about $45,000. Institutional investors own 86.99% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently commented on CI. Royal Bank of Canada decreased their target price on The Cigna Group from $384.00 to $377.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Truist Financial decreased their target price on The Cigna Group from $390.00 to $375.00 and set a "buy" rating on the stock in a research report on Tuesday, February 4th. Piper Sandler reiterated an "overweight" rating and issued a $348.00 target price (down from $394.00) on shares of The Cigna Group in a research report on Monday, February 3rd. Cantor Fitzgerald decreased their target price on The Cigna Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research report on Friday, January 31st. Finally, UBS Group decreased their target price on The Cigna Group from $410.00 to $390.00 and set a "buy" rating on the stock in a research report on Monday, February 3rd. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Buy" and an average target price of $373.69.

The Cigna Group Trading Up 0.9 %

Shares of CI traded up $2.67 during mid-day trading on Thursday, reaching $299.90. 1,269,997 shares of the company's stock traded hands, compared to its average volume of 1,794,170. The stock has a market cap of $83.42 billion, a P/E ratio of 24.50, a P/E/G ratio of 0.97 and a beta of 0.54. The stock's 50-day moving average is $285.65 and its two-hundred day moving average is $319.92. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72.

The Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts' consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the prior year, the firm posted $6.79 EPS. Research analysts forecast that The Cigna Group will post 29.77 earnings per share for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a $1.51 dividend. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $6.04 annualized dividend and a yield of 2.01%. This is a boost from The Cigna Group's previous quarterly dividend of $1.40. The Cigna Group's dividend payout ratio is 45.75%.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.